Transform your genome into a computational model that predicts drug response, quantifies disease risk, and identifies optimal interventions — unique to your biology.
The technology stack powering the future of precision medicine — from variant calling to clinical decision support.
Predict drug metabolism, efficacy, and adverse reactions from CYP450 variants, transporters, and drug targets. Right drug, right dose, first time — eliminating trial-and-error prescribing.
Aggregate thousands of genetic variants into actionable risk predictions. Cardiovascular, oncologic, metabolic, and neurological conditions — quantified before symptoms emerge.
Match patients to optimal therapies via genetic markers. Evidence-based matching across oncology, psychiatry, and cardiology.
Screen for hundreds of recessive disease variants. CF, sickle cell, Tay-Sachs — comprehensive preconception intelligence.
Your GeneTwin evolves with science. Continuous updates as new gene-drug associations and pathogenicity classifications emerge.
CPIC and DPWG guideline-aligned recommendations delivered at the point of care. EHR-integrated, real-time pharmacogenomic alerts that prevent adverse drug events before they occur.
Every nucleotide sequenced. Every variant cataloged. Your complete genomic identity rendered as an interactive computational model.
3.2 billion base pairs. 20,000 protein-coding genes. One digital twin that captures it all — a living computational mirror of your biology.
A rapidly expanding market driven by falling sequencing costs, regulatory momentum, and clinical validation.
This premium domain is available for acquisition. Ideal for precision medicine platforms, biotech startups, and genomic testing services entering the digital twin space.